Publications by authors named "Anna Schweda"

Claim this Profile
E
Etrolizumab-s fails to control E-Cadherin-dependent co-stimulation of highly activated cytotoxic T cells.
Maximilian Wiendl, Mark Dedden, Li-Juan Liu, Anna Schweda, Eva-Maria Paap

Nat Commun· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etrolizumab-s Does Not Induce Residual Trafficking of Regulatory T Cells.
Anna Schweda, Emily Becker, Maximilian Wiendl, Raja Atreya, Imke Atreya

Inflamm Bowel Dis· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Residual homing of α4β7-expressing β1PI16 regulatory T cells with potent suppressive activity correlates with exposure-efficacy of vedolizumab.
Emily Becker, Mark Dedden, Christine Gall, Maximilian Wiendl, Arif Bülent Ekici, Anna Schweda

Gut· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limited Dose-Dependent Effects of Vedolizumab on Various Leukocyte Subsets.
Emily Becker, Anna Schweda, Karen A-M Ullrich, Caroline Voskens, Raja Atreya

Clin Transl Gastroenterol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis